VGXI Inc. News and Resources

VGXI, Inc., a CDMO specialising in nucleic acid biopharmaceuticals, has announced its acceptance into the Biopharmaceutical Manufacturing Preparedness (BioMap) Consortium. This consortium, supported by the Biomedical Advanced Research and Development Authority (BARDA), aims to strengthen the United States’ biopharmaceutical manufacturing